1. Docetaxel under review with EMA

   News item 25 March 2017 Pages: 1 - 1

2. Gadolinium contrast agents: marketing suspensions by PRAC

   News item 25 March 2017 Pages: 2 - 2

3. Health Canada issues foreign health product alert

   News item 25 March 2017 Pages: 3 - 3

4. Illegal medicines detained by Ireland's HPRA: 2016 results

   News item 25 March 2017 Pages: 4 - 4

5. TGA: do not use Zostavax in immunocompromised patients

   News item 25 March 2017 Pages: 5 - 5

6. Valproate in pregnancy or childbearing females: PRAC review

   News item 25 March 2017 Pages: 6 - 6

7. Adverse cardiovascular events following fertility therapy failure

   Clinical study 25 March 2017 Pages: 7 - 7

8. Anabolic androgens increase comorbid health conditions

   Clinical study 25 March 2017 Pages: 8 - 8

9. Childhood influenza vaccination: perceptions and uptake

   Clinical study 25 March 2017 Pages: 9 - 9

10. Elderly with hip fractures use antidepressants, benzodiazepines

    News item 25 March 2017 Pages: 10 - 10

11. Ketoacidosis with SGLT2 inhibitors in Denmark over 20 years

    Clinical study 25 March 2017 Pages: 11 - 11

12. Serious ADEs associated with number of dispensed medications

    Clinical study 25 March 2017 Pages: 12 - 12

13. Adalimumab

    Case report 25 March 2017 Pages: 13 - 13

14. Adalimumab/certolizumab-pegol

    Case report 25 March 2017 Pages: 14 - 14

15. Adefovir/lamivudine

    Case report 25 March 2017 Pages: 15 - 15

16. Alemtuzumab

    Case report 25 March 2017 Pages: 16 - 16

17. Alendronic acid/raloxifene

    Case report 25 March 2017 Pages: 17 - 17

18. Allopurinol/azathioprine interaction

    Case report 25 March 2017 Pages: 18 - 18

19. Alteplase

    Case report 25 March 2017 Pages: 19 - 19

20. Amoxicillin

    Case report 25 March 2017 Pages: 20 - 20

21. Amoxicillin/azithromycin

    Case report 25 March 2017 Pages: 21 - 21

22. Anaesthetics/metoprolol/ziconotide

    Case report 25 March 2017 Pages: 22 - 22

23. Antibacterials/carbamazepine

    Case report 25 March 2017 Pages: 23 - 23

24. Antihypertensives and rifapentine

    Case report 25 March 2017 Pages: 24 - 24

25. Antineoplastics

    Case report 25 March 2017 Pages: 25 - 25

26. Antineoplastics

    Case report 25 March 2017 Pages: 26 - 26

27. Antineoplastics

    Case report 25 March 2017 Pages: 27 - 27

28. Antineoplastics

    Case report 25 March 2017 Pages: 28 - 28

29. Antineoplastics

    Case report 25 March 2017 Pages: 29 - 29

30. Antineoplastics

    Case report 25 March 2017 Pages: 30 - 30

31. Antineoplastics

    Case report 25 March 2017 Pages: 31 - 31

32. Antineoplastics

    Case report 25 March 2017 Pages: 32 - 32

33. Antineoplastics

    Case report 25 March 2017 Pages: 33 - 33

34. Antineoplastics

    Case report 25 March 2017 Pages: 34 - 34

35. Antineoplastics

    Case report 25 March 2017 Pages: 35 - 35

36. Antineoplastics/metronidazole

    Case report 25 March 2017 Pages: 36 - 36

37. Antiparkinsonians/GABA-A-receptor-agonists

    Case report 25 March 2017 Pages: 37 - 37

38. Antithymocyte-globulin/busulfan/fludarabine

    Case report 25 March 2017 Pages: 38 - 38

39. Antithymocyte-globulin/tacrolimus

    Case report 25 March 2017 Pages: 39 - 39

40. Apomorphine

    Case report 25 March 2017 Pages: 40 - 40

41. Aspirin

    Case report 25 March 2017 Pages: 41 - 41

42. Aspirin

    Case report 25 March 2017 Pages: 42 - 42

43. Aspirin/clopidogrel

    Case report 25 March 2017 Pages: 43 - 43

44. Aspirin/clopidogrel/rivaroxaban

    Case report 25 March 2017 Pages: 44 - 44

45. Aspirin/diclofenac

    Case report 25 March 2017 Pages: 45 - 45

46. Atorvastatin

    Case report 25 March 2017 Pages: 46 - 46

47. Atorvastatin

    Case report 25 March 2017 Pages: 47 - 47

48. Azacitidine

    Case report 25 March 2017 Pages: 48 - 48

49. Azacitidine

    Case report 25 March 2017 Pages: 49 - 49

50. Azathioprine

    Case report 25 March 2017 Pages: 50 - 50